y 50% of melanoma patients and can be identified with a diagnostic test. "Many more inhibitors and combination drugs need to pass through the FDA's Accelerated Program," Jeffrey Epstein remarked, who also heads the Jeffrey Epstein VI Foundation, which funds science research around the world. Indeed, the FDA only s